Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
—
—
—
—
—
—
1 Year
Score—
Net Growth—
Net Trend—
Net Income Consistency—
Rev Growth—
Rev Trend—
Revenue Consistency—
5 Years
—
—
50%
—
—
75%
—
5 Years
Score—
Net Growth—
Net Trend50%
Net Income Consistency—
Rev Growth—
Rev Trend75%
Revenue Consistency—
Alterity Therapeutics Ltd fundamental performance
Across Alterity Therapeutics Ltd's full reported history, from 2003 to 2025, revenue grew from $ 1M to $ 5M and net income went from -$ 4M to -$ 12M. Revenue increased in 45% of the years measured; net income in 45%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 4.91 | — |
1 Year2025-08-12 | $ 5.30 | -7.36% |
5 Years2021-08-12 | $ 13.80 | -64.42% |
10 Years2016-08-12 | $ 57.00 | -91.39% |
20 Years2006-08-11 | $ 134.40 | -96.35% |
All Time2002-09-05 | $ 678.00 | -99.28% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | All Time2002-09-05 |
|---|---|---|---|---|---|---|
| Price | $ 4.91 | $ 5.30 | $ 13.80 | $ 57.00 | $ 134.40 | $ 678.00 |
| Return | — | -7.36% | -64.42% | -91.39% | -96.35% | -99.28% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 49M | ||
| 2025 | $ 5M | -$ 12M | $ 40M |
| 2024 | $ 4M | -$ 19M | $ 12M |
| 2023 | $ 3M | -$ 13M | $ 15M |
| 2022 | $ 5M | -$ 12M | $ 34M |
| 2021 | $ 4M | -$ 15M | $ 28M |
| 2020 | $ 411.57K | -$ 10M | $ 9M |
| 2019 | $ 108.54K | -$ 11M | $ 14M |
| 2018 | $ 201.17K | -$ 8M | $ 15M |
| 2017 | $ 132.4K | -$ 7M | $ 21M |
| 2016 | $ 142.66K | -$ 7M | $ 28M |
| 2015 | $ 176.84K | -$ 5M | $ 35M |
| 2014 | $ 363.77K | -$ 13M | $ 34M |
| 2013 | $ 150.87K | -$ 7M | $ 13M |
| 2012 | $ 186.66K | -$ 5M | $ 5M |
| 2011 | $ 156.13K | -$ 6M | $ 8M |
| 2010 | $ 215.01K | -$ 4M | $ 5M |
| 2009 | $ 428.19K | -$ 7M | $ 4M |
| 2008 | $ 492K | -$ 13M | $ 11M |
| 2007 | $ 507.04K | -$ 11M | $ 7M |
| 2006 | $ 762.49K | -$ 11M | $ 10M |
| 2005 | $ 2M | -$ 24M | $ 21M |
| 2004 | $ 2M | -$ 9M | $ 29M |
| 2003 | $ 1M | -$ 4M | $ 3M |
Explore beyond ATHE
You're looking at Alterity Therapeutics Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
